ENSURE_3A: ENSURE, figure 3A

In raredd/kmdata: A Database of Reconstructed Individual Patient Level Data from Oncology Clinical Trials

ENSURE, figure 3A

Description

Kaplan-Meier digitized data from ENSURE, figure 3A (PMID 26105600). A reported sample size of 217 for a primary endpoint of PFS in lung cancer.

Usage

ENSURE_3A

Format

A data frame of 217 observations and 3 variables:

	time	event time (in months)
	event	OS event indicator (0: no event, 1: event)
	arm	treatment arms (erlotinib, gp)

Source

Wu Y-L, Zhou C, Liam C-K, et al. First-line erlotinib versus gemcitabine/cisplatin in patients with advanced EGFR mutation-positive non-small-cell lung cancer: analyses from the phase III, randomized, open-label, ENSURE study. Ann Oncol 2015; 26: 1883–9.

Examples

summary(ENSURE_3A)

kmplot(ENSURE_3A)

raredd/kmdata documentation built on June 15, 2025, 9:33 a.m.